Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Some drugs for inflammation may cause psoriasis-like hair loss.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Etanercept may cause lichen planopilaris, so doctors should be cautious.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

TNF-a may not be as involved in certain types of hair loss as previously thought.

Different races and genders have unique skin and hair issues, requiring specialized care and more research for effective treatment.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Adalimumab may cause severe hair loss in some patients.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Cells lacking the Bax protein can outcompete others, leading to better tissue repair and hair growth.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Eating a high-fat fish oil diet caused mice to lose hair due to a specific immune cell activity in the skin linked to a protein called E-FABP.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.